1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Critical Therapeutics

Anonymous board for Critical Therapeutics


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    0
    Views:
    3,032
  2. Anonymous
    Replies:
    1
    Views:
    4,629
  3. Anonymous
    Replies:
    1
    Views:
    2,888
  4. Anonymous
    Replies:
    734
    Views:
    105,473
  5. Anonymous
    Replies:
    17
    Views:
    12,572
  6. Anonymous
    Replies:
    0
    Views:
    3,472
  7. Anonymous
    Replies:
    130
    Views:
    22,281
  8. Anonymous
    Replies:
    20
    Views:
    6,348
  9. Anonymous
    Replies:
    15
    Views:
    6,119
  10. Anonymous
    Replies:
    0
    Views:
    3,266

Thread Display Options

Loading...